Table 4.
Cox multivariate analysis of SOX11 and MIPI in relation to overall and event free survival in the MCL2/3 cohort.
| Patients (n) | HR | 95% CI | P-value* | |
|---|---|---|---|---|
| Overall survival | ||||
| SOX11high | 74 | 1·0 | ||
| SOX11low | 37 | 2·3 | 1·2–4·6 | 0·017 |
| MIPI (continuous) | 111 | 3·2 | 2·1–4·9 | <0·001 |
| Event-free survival | ||||
| SOX11high | 74 | 1·0 | ||
| SOX11low | 37 | 2·2 | 1·3–4·0 | 0·005 |
| MIPI (continuous) | 111 | 2·4 | 1·6–3·6 | <0·001 |
HR, hazard ratio; 95% CI, 95% confidence interval; MIPI, Mantle cell lymphoma International Prognostic Index.
*
Statistical significant P-values are shown in bold.